Read Larry Connors' blog – Short Term Trading Strategies
Visit: http://www.stockguru.com to register for our daily Stocks to Watch and Trade Alerts.
ROK Entertainment Group Inc. (OTCBB: ROKE | Quote | Chart | News | PowerRating) Shares stayed steady at $1.50
ROK Entertainment Group, founded in 2004, is a global mobile entertainment group. ROK has filed more than 40 international patents for its suite of revenue-generating mobile technologies, applications and services
ROKE News Friday, ROK Entertainment announced it has undergone a process of re-alignment to include a management reorganization. Laurence Alexander, who joined ROK as CEO in June 2007, will leave the company while Jonathan Kendrick, the original founder of ROK, will return as CEO. ''This change of leadership has been reached amicably and by mutual agreement,'' said Kendrick, ''and we thank Laurence for all his efforts and wish him well for the future.''
Intermountain Community Bancorp (OTCBB: IMCB | Quote | Chart | News | PowerRating) Shares traded down 1.74% at $5.65
Intermountain Community Bancorp operates as the holding company for Panhandle State Bank that provides commercial banking services primarily to individuals, professionals, and small to medium-sized businesses in the United States. It offers deposit products, including checking accounts, savings accounts, money market accounts, and certificates of deposit. The company also provides consumer loans, including personal loans, motor vehicle loans, boat loans, recreational vehicle loans, home improvement loans, home equity loans, secured and unsecured open-end credit lines, and overdraft protection credit lines; commercial loans for working capital, inventory acquisition, equipment purchases, and business expansion; real estate loans, including first mortgage loans to purchase or refinance homes; and residential loans and municipal financing loans. In addition, it offers non-FDIC insured investment products and services, which include annuities, equity and fixed income securities, mutual funds, insurance products, and brokerage services; and trust and wealth management services in investment, tax, and estate planning to higher net worth customers. Further, the company provides automated teller machines, debit cards, safe deposit boxes, merchant credit card acceptance, savings bonds, remote deposit capture, direct and night deposit, cash management, Internet and phone banking, VISA/Mastercard credit cards, and ACH origination services. As of December 31, 2007, it operated a main office in Sandpoint, Idaho; and 18 branches, of which 16 are in Bonners Ferry, Caldwell, Coeur d?Alene, Fruitland, Gooding, Kellogg, Nampa, Payette, Ponderay, Post Falls, Priest River, Rathdrum, Sandpoint, Twin Falls, and Weiser cities in Idaho; and 2 branches in Spokane Valley and Spokane in Washington. Intermountain Community Bancorp also operates a branch in Ontario, Oregon. The company was founded in 1981 and is headquartered in Sandpoint, Idaho.
IMCB News Friday, Intermountain Community announced approval for participation in the Treasury Department's voluntary Capital Purchase Program. As a participant in the program, Intermountain may issue up to $27 million in preferred stock with warrants to purchase up to approximately $4 million in common stock. As a condition of the approval, Intermountain will call a Special Meeting of its shareholders to approve amending its Articles of Incorporation to provide for the issuance of preferred stock, and will file proxy materials with the Securities and Exchange Commission for that purpose.
Redpoint Bio Corporation (OTCBB: RPBC | Quote | Chart | News | PowerRating) Shares traded down 48% at $0.13
Redpoint Bio is leveraging recent discoveries in the molecular biology of taste to discover and develop novel taste modulators for the food, beverage and pharmaceutical industries. Redpoint Bio's food and beverage program is focused on identifying novel compounds that improve the tastes of existing ingredients and enable the development of better-tasting and more healthful foods and beverages. The pharmaceutical program uses a biochemical approach aimed at suppressing the bitterness of medicines, which has the potential to expand the range of formulation options and increase patient compliance.
RPBC News Friday, Redpoint Bio announced financial and operational results for the three and nine months ended September 30, 2008. For the three and nine months ended September 30, 2008, Redpoint recorded revenue of $1.1 million, and $3.0 million, respectively, which includes revenue generated from the Company's research and development collaboration with Givaudan, signed in March 2007, and services performed under Redpoint's research and technology development agreement with The Coca-Cola Company, signed in December 2007. For the three and nine month periods ended September 30, 2007, Redpoint recorded revenue of $0.7 million and $1.4 million, respectively, from the commencement of the Company's research and development collaboration with Givaudan.
Global Telecom & Technology, Inc. (OTCBB: GTLT | Quote | Chart | News | PowerRating) Shares traded down 12.5% at $0.35
Global Telecom & Technology, Inc., through its subsidiaries, provides facilities-neutral, high-capacity communications network solutions, managed data networks, and other telecommunications services primarily in the United States, the United Kingdom, and Germany. It offers point-to-point private lines and bundled private line hub solutions; Ethernet-enabled private line solutions, inter-LAN connectivity solutions, and Ethernet-based Internet access; high speed connectivity to the Internet; virtual-private network services (VPN), including IP-VPN, MPLS, and Ethernet-based VPLS services; and wireless services. The company also provides managed services, including monitoring, maintenance, and management of customers? telecommunications circuits and network systems, as well as co-location, equipment support, or network security solutions. Global Telecom & Technology serves customers in the banking, manufacturing, communications, and media industries. It has a strategic agreement with FiberLight, LLC. The company was founded in 1998 and is headquartered in McLean, Virginia.
GTLT News Friday, Global Telecom & Technology announced its plans to release results for the third quarter ended September 30, 2008 on Wednesday, November 12, 2008 after the market closes. In conjunction with the release, GTT has scheduled a conference call, which will also be broadcast live over the Internet, on Thursday, November 13, 2008 at 8:30 A.M. Eastern Time.
Power3 Medical Products, Inc. (OTCBB: PWRM | Quote | Chart | News | PowerRating) Shares traded down 8.7% at $0.021
Power3 Medical Products, Inc., a development stage company, engages in the early detection, monitoring, and targeting of diseases through the analysis of proteins. It focuses on disease diagnosis, protein and biomarker identification, and early detection indicators in the areas of cancers, such as breast, leukemia, bladder, stomach, and esophageal; and neurodegenerative diseases, such as Alzheimer?s and Parkinson?s disease. Power3 Medical Products has collaboration agreement with University of Thessaly School of Medicine focusing on the proteomic discovery of biomarkers for Parkinson?s disease; and with NeoGenomics, Inc. to form a joint venture contract research organization for the commercialization of the company?s portfolio of intellectual property. It also has collaboration agreements with the Princess Haya Biotechnology Center and Jordan University For Science & Technology. The company was founded in 1992 and is based in Woodlands, Texas.
PWRM News Friday, Power3 Medical Products announced that Dr. Marwan Sabbagh, Chief Medical-Scientific Officer of Sun Health and Dr. Ira L. Goldknopf, President and Chief Scientific Officer of Power3, have jointly submitted an abstract entitled "Development of a novel biomarker approach for detection of Alzheimer's disease" for presentation by Dr. Sabbagh to the 61st annual meeting of the American Academy of Neurology to take place in Seattle on April 25 - May 1, 2009. Power3 Medical is a leading biomedical company specializing in the development and commercialization of protein based diagnostic blood tests for the early detection of breast cancer and neurodegenerative diseases.
Omtool, Ltd. (OTCBB: OMTL | Quote | Chart | News | PowerRating) Shares traded down 20% at $1.00
Omtool, Ltd. is a leading provider of document capture and handling solutions that simplify the integration of paper and electronic documents in enterprise information management systems. Its flagship product family, AccuRoute, streamlines the capture, conversion, communication and archive of paper and electronic documents, enabling fast, secure, simultaneous distribution to multiple destinations in multiple formats. Available at any network-enabled scan device or from a user's desktop computer, AccuRoute provides faster, more efficient workflows, while reducing cost, complexity and risk. Omtool solutions are used worldwide by businesses in document-intensive industries that demand secure handling, integration and tracking of documents in full compliance with a range of regulatory requirements.
OMTL News Friday, Omtool reported results of operations for the third quarter of fiscal year 2008. Total revenue for the quarter ended September 30, 2008 was consistent with the total revenue reported for the quarter ended September 30, 2007, at approximately $4.1 million. Service and other revenue increased by $281,000 and hardware revenue increased by $110,000 during the third quarter of 2008 as compared to the same quarter of 2007. These increases were offset by a decline of approximately $390,000 in software license revenue during the third quarter of 2008 as compared to the same period in 2007. However, during the third quarter of 2008, Omtool entered into a contract with one of its large partners to provide products and services to a large financial services company. The total contract value is in excess of $1.0 million and is comprised primarily of software licenses and certain associated services. Omtool has classified the contract in its deferred revenue for the current quarter and expects to recognize the revenue for this contract over the ensuing fiscal quarters.
About StockGuru.com:
StockGuru.com is an investment information web site for smallcap and over-the-counter bulletin board stocks. StockGuru features daily email alerts to members, company profiles, audio interviews of CEO's or other key executives, and company news. Company and financial reports are authored by business analysts. To join our email alert list, please visit: http://www.stockguru.com/index.php?option=com_content&view=article&id=31&Itemid=5
About ShareholderVision.com:
Occasionally companies mentioned are also featured at ShareholderVision.com. This innovative web site featuring company videos of corporate executives and key personnel. All videos are shot in high-definition format and are edited for content purposes.
To feature your publicly traded company in our alerts, or to discuss our complete services, please contact: John Pentony at (469) 252-3031, or you email us at email: john@stockguru.com and we will gladly send you more information on featuring your company with StockGuru.com
Stockguru.com ("SG") provides its members with the latest news, press releases, and research reports for all the companies highlighted on the site. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.Stockguru.com or mentioned herein.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies= annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements.
CONTACT: John Pentony, Publisher, Stockguru.com Tel: +1 469 252 3031 e-mail: john@stockguru.com WWW: http://www.stockguru.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
